Together, our results provide a mechanism that BRCA1 attenuates AR-stimulated proliferation of breast cancer cells via SIRT1 mediated pathway and illustrate the great potential of developing new AR-targeting therapy for BRCA1-mutated breast cancer patients. This evidence concerns the gene AR and breast carcinoma.